A Different View: What it Looks Like When you Listen to Patients

Speaker: Deborah Marshall

Date: Friday, November 18th from 10 AM – 12 PM

Location: HS 100 (Health Sciences Building, 155 College Street, Toronto ON)


Uncertainty is inherent in medical decision making. In recent years there has been a growing movement to engage patients and to inform decisions by the more formal study of patient preferences in health care. A greater understanding of what is important to the patient, as the user of health care services, can help inform decision making and increase the value of health care services. This presentation will highlight discrete choice experiments as a method to measure patient preferences and discuss how these methods can be used to explore what is important to patients and how they consider trade-offs amongst types of health care tests and treatments. It will also discuss how these methods are being explored and applied in the regulatory context to promote more patient-centered decision making.





Deborah Marshall holds a Canada Research Chair, Health Services and Systems Research as a Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health. She is the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist at Arthritis Research Canada, and a member of the O’Brien Institute of Public Health. She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe.  Her health technology assessment and health services research program focuses on patient preferences and patient engagement research, cost-effectiveness analysis, and dynamic simulation modeling of health services delivery to improve the effectiveness and efficiency of health care services. Dr. Marshall is also an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as the Past President of the Board of Directors and various Task Forces, and a member Board of Directors for Health Technology Assessment International (HTAi).